Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Idera Pharmaceuticals Inc (NASDAQ:IDRA)

1.66
Delayed Data
As of Apr 29
 -0.05 / -2.92%
Today’s Change
1.50
Today|||52-Week Range
4.42
-46.28%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues34.0K5.0K20.0K190.0K
 
 
 
 
 
Depreciation And Amortization101.0K112.0K133.0K159.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses12.5M12.7M11.4M12.1M
 
 
 
 
 
Research And Development8.7M9.0M7.5M8.6M
 
 
 
 
 
Total Operating Expenses12.6M12.8M11.5M12.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.5M-12.8M-11.5M-12.1M
 
 
 
 
 
Interest Expense On Debt0.000.0027.0K24.0K
 
 
 
Other Expenses28.0K9.0K3.0K-1.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.5M-12.7M-11.4M-12.0M
 
 
 
 
 
Net Income-12.5M-12.7M-11.4M-12.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS105.1M118.0M118.2M118.9M
 
 
 
 
 
Shares To Calculate EPS Diluted105.1M118.0M118.2M118.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12-$0.11-$0.10-$0.10
 
 
 
 
 
EPS Diluted-$0.12-$0.11-$0.10-$0.10